19.12.2012 Views

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

Anemia of Prematurity - Portal Neonatal

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Interactions<br />

suspected necrotizing enterocolitis (NEC)<br />

May interfere with renal excretion <strong>of</strong> drugs (eg, gentamicin); may<br />

increase serum potassium levels when administered with potassiumsparing<br />

diuretics<br />

Pregnancy B - Usually safe but benefits must outweigh the risks.<br />

Precautions<br />

Pregnancy category D if used for more than 48 h or after 34 wk <strong>of</strong><br />

gestation; fluid and electrolyte imbalance including hyperkalemia;<br />

possible cerebral hypoperfusion and ischemia; alterations in regional<br />

blood flow including gastrointestinal and renal;acute renal failure; oliguria<br />

Drug Category: Carbonic anhydrase inhibitors -- Suppress CSF production.<br />

Drug Name<br />

Pediatric Dose<br />

Contraindications<br />

Acetazolamide (Diamox) -- The suppression <strong>of</strong> CSF production in slowly<br />

progressive ventricular dilation is controversial. Acetazolamide is a<br />

competitive and reversible inhibitor <strong>of</strong> carbonic anhydrase.<br />

5 mg/kg/dose PO/IV q6h initially; increase by 25 mg/kg/d; not to exceed<br />

100 mg/kg/d<br />

Patients with hyperchloremic acidosis; decreased serum sodium and/or<br />

potassium<br />

Interactions May increase the excretion <strong>of</strong> phenobarbital<br />

Pregnancy C - Safety for use during pregnancy has not been established.<br />

Precautions<br />

Hypercalciuria and nephrocalcinosis (especially in combination with<br />

furosemide); possible interference with CNS myelination; metabolic<br />

acidosis; hypokalemia; hepatic dysfunction<br />

FOLLOW-UP Section 8 <strong>of</strong> 11<br />

Further Inpatient Care: Developmental intervention programs<br />

Further Outpatient Care:<br />

• Neurological follow-up<br />

• Developmental follow-up<br />

Deterrence/Prevention:<br />

• Prevention <strong>of</strong> PVH-IVH begins with avoidance <strong>of</strong> conditions that do the following:<br />

o Interfere with autoregulation (eg, hypocarbia, hypercarbia, hypoxia, acidosis<br />

o Overwhelm autoregulatory abilities (eg, hypertension)<br />

o Contribute to rapid fluctuations <strong>of</strong> cerebral blood flow (eg, ventilatory asynchrony,<br />

rapid volume expansion, noxious stimuli, frequent handling)<br />

• Perform correction <strong>of</strong> host factors (eg, coagulopathy, acid-base balance, hydration, hypoxiaischemia).<br />

• Pharmacological prophylaxis can be accomplished through the use <strong>of</strong> indomethacin. Although<br />

the mechanism <strong>of</strong> action is currently unknown, indomethacin has been shown to reduce the<br />

incidence <strong>of</strong> PVH-IVH and, specifically, high-grade hemorrhages. Follow-up <strong>of</strong> patients<br />

enrolled in a multicenter prophylaxis study conducted by Ment is encouraging. Although motor<br />

skills are not different when patients are aged 4.5 years, cognitive and social skills appear<br />

better in patients receiving prophylaxis. However, because <strong>of</strong> complications, this therapy is<br />

not universally accepted and remains controversial.<br />

• In addition to effects on pulmonary development, prenatal treatment with glucocorticoids has a<br />

protective effect with regard to PVH-IVH.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!